Clinical Performance Evaluation of Sansure Hepatitis C Virus RNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing)
- Conditions
- Hepatitis C is an inflammation of the liver caused by the hepatitis C virus (HCV). HCV is transmitted through blood, for example through drug use. Hepatitis C is often chronic, but can almost always be cured in a maximum of three months. Without treatment, hepatitis C can lead to liver failure or liver cancer.
- Registration Number
- DRKS00034144
- Lead Sponsor
- Sansure Biotech Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 144
HBV negative
Specificity:
-HBV Antigen positive/ negative samples
Interference:
HBV negative Proben with
-Hepatitis A virus (HAV) positive
-Human Immunodeficiency Virus (HIV) positive
-Hepatitis C virus (HCV) positive
-Influenza A virus (IAV) positive
-Human Cytomegalovirus (CMV) positive
-Candida albicans positive
-Epstein-Barr virus (EBV) positive
-Treponema pallidum positive
-Herpes simplex virus 2 (HHV-2) positive
-Staphylococcus aureus positive
-Sample was not frozen
-Tube was damaged
-No blinding ID
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method diagnostic specificity (DSpec) represented by negative percentage agreement, NPA) <br>Diagnostic Specificity=NPA=B2/((B1+B2)=TN/((FP+TN) ))
- Secondary Outcome Measures
Name Time Method crossreactivity tested against genomes of:<br>-Hepatitis A virus (HAV)<br>-Human Immunodeficiency Virus (HIV)<br>-Hepatitis C virus (HCV)<br>-Influenza A virus (IAV)<br>-Human Cytomegalovirus (CMV)<br>-Candida albicans<br>-Epstein-Barr virus (EBV)<br>-Treponema pallidum<br>-Herpes simplex virus 2 (HHV-2)<br>-Staphylococcus aureus<br><br>interference tested in:<br>- Women who have had more than one pregnancy<br>- Rheumatoid factor positive samples<br>- anti- E. coli antibodies <br>- anti-Candida albicans antibodies